Portfolio Building Block World Pharma and Biotech Index ETF
ETFYour view on PBPH
Portfolio Building Block World Pharma and Biotech Index ETF
ETFPortfolio Building Block ETFsSentiment
AUM (USD)
$1.02B
Expense Ratio
0.13%
Holdings
0
Sentiment
Overview for Portfolio Building Block World Pharma and Biotech Index ETF
- Fund Type
- ETF
- Fund Issuer
- Portfolio Building Block ETFs
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- November 24, 2025
- Domicile
- US
- Fund Type
- ETF
- Fund Issuer
- Portfolio Building Block ETFs
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- November 24, 2025
- Domicile
- US
- Fund Type
- ETF
- Fund Issuer
- Portfolio Building Block ETFs
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- November 24, 2025
- Domicile
- US
About this fund
The Portfolio Building Block World Pharma and Biotech Index ETF seeks to provide investors with targeted exposure to the global pharmaceutical and biotechnology industries, two of the most dynamic and innovation-driven sectors in healthcare. The fund seeks to replicate the perfor…
PBPH Stock Price
Key Facts
EquityExpense Ratio
0.13%
AUM
$1.02B
Fund Details
Expense Ratio
0.13%
Assets Under Management
$1.02B
NAV
$28.16 USD
Average Volume
122.3K
Inception Date
November 24, 2025
Asset Class
Equity
Fund Issuer
Portfolio Building Block ETFs
Domicile
US
ISIN
US88635A2042
CUSIP
88635A204
NAV Currency
USD
Expense Ratio
0.13%
Assets Under Management
$1.02B
NAV
$28.16 USD
Average Volume
122.3K
Inception Date
November 24, 2025
Asset Class
Equity
Fund Issuer
Portfolio Building Block ETFs
Domicile
US
ISIN
US88635A2042
CUSIP
88635A204
NAV Currency
USD
Latest headlines and company announcements for this company. Press releases and market coverage, newest first.
News
this company valued side by side against its closest peers. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.